| Year |
Citation |
Score |
| 2017 |
Naylor JE, Hiranita T, Matazel KS, Zhang X, Paule MG, Goodwin AK. Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [(18)F]Fallypride. Drug and Alcohol Dependence. 179: 254-259. PMID 28818716 DOI: 10.1016/J.Drugalcdep.2017.07.013 |
0.319 |
|
| 2016 |
Goodwin AK. An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates. Journal of Pharmacological and Toxicological Methods. 82: 31-36. PMID 27473331 DOI: 10.1016/J.Vascn.2016.07.004 |
0.402 |
|
| 2015 |
Goodwin AK, Hiranita T, Paule MG. The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25673111 DOI: 10.1093/Ntr/Ntv002 |
0.358 |
|
| 2015 |
Goodwin AK, Lantz-McPeak SM, Robinson BL, Law CD, Ali SF, Ferguson SA. Effects of adolescent treatment with nicotine, harmane, or norharmane in male Sprague-Dawley rats. Neurotoxicology and Teratology. 47: 25-35. PMID 25450662 DOI: 10.1016/J.Ntt.2014.10.005 |
0.353 |
|
| 2013 |
Goodwin AK, Gibson KM, Weerts EM. Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons. Drug and Alcohol Dependence. 132: 427-33. PMID 23538206 DOI: 10.1016/J.Drugalcdep.2013.02.035 |
0.397 |
|
| 2013 |
Goodwin AK, Mueller M, Shell CD, Ricaurte GA, Ator NA. Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons. The Journal of Pharmacology and Experimental Therapeutics. 345: 342-53. PMID 23516331 DOI: 10.1124/Jpet.113.203729 |
0.405 |
|
| 2013 |
Goodwin AK, Kaminski BJ, Weerts EM. Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 225: 637-46. PMID 22945514 DOI: 10.1007/S00213-012-2851-5 |
0.421 |
|
| 2011 |
Mueller M, Goodwin AK, Ator NA, McCann UD, Ricaurte GA. Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences. The Journal of Pharmacology and Experimental Therapeutics. 338: 310-7. PMID 21493752 DOI: 10.1124/Jpet.111.180612 |
0.319 |
|
| 2011 |
Goodwin AK, Kaminski BJ, Griffiths RR, Ator NA, Weerts EM. Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons. Drug and Alcohol Dependence. 114: 217-24. PMID 21112162 DOI: 10.1016/J.Drugalcdep.2010.10.006 |
0.419 |
|
| 2009 |
Goodwin AK, Brown PR, Jansen EE, Jakobs C, Gibson KM, Weerts EM. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 204: 465-76. PMID 19198808 DOI: 10.1007/S00213-009-1477-8 |
0.422 |
|
| 2007 |
Weerts EM, Fantegrossi WE, Goodwin AK. The value of nonhuman primates in drug abuse research. Experimental and Clinical Psychopharmacology. 15: 309-27. PMID 17696678 DOI: 10.1037/1064-1297.15.4.309 |
0.363 |
|
| 2006 |
Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM, Weerts EM. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology. 189: 71-82. PMID 17047936 DOI: 10.1007/S00213-006-0534-9 |
0.392 |
|
| 2006 |
Struys EA, Verhoeven NM, Jansen EE, Ten Brink HJ, Gupta M, Burlingame TG, Quang LS, Maher T, Rinaldo P, Snead OC, Goodwin AK, Weerts EM, Brown PR, Murphy TC, Picklo MJ, et al. Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase. Metabolism: Clinical and Experimental. 55: 353-8. PMID 16483879 DOI: 10.1016/J.Metabol.2005.09.009 |
0.355 |
|
| 2005 |
Goodwin AK, Froestl W, Weerts EM. Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology. 180: 342-51. PMID 15739078 DOI: 10.1007/S00213-005-2165-Y |
0.388 |
|
| 2005 |
Weerts EM, Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology. 179: 678-87. PMID 15645222 DOI: 10.1007/S00213-004-2079-0 |
0.406 |
|
| 2003 |
Goodwin AK, Pynnonen DM, Baker LE. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination. Pharmacology, Biochemistry, and Behavior. 74: 987-95. PMID 12667914 DOI: 10.1016/S0091-3057(03)00029-7 |
0.647 |
|
| 2002 |
Goodwin AK, Baker LE. An analysis of the utility of differential outcome procedures in drug discrimination research. Behavioural Pharmacology. 13: 271-8. PMID 12218507 DOI: 10.1097/00008877-200207000-00003 |
0.58 |
|
| 2001 |
Christian AJ, Goodwin AK, Baker LE. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacology, Biochemistry, and Behavior. 68: 371-7. PMID 11325388 DOI: 10.1016/S0091-3057(00)00470-6 |
0.634 |
|
| 2000 |
Goodwin AK, Baker LE. A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats. Experimental and Clinical Psychopharmacology. 8: 415-23. PMID 10975633 DOI: 10.1037//1064-1297.8.3.415 |
0.65 |
|
| 1999 |
Goodwin AK. A THREE-LEVER DRUG DISCRIMINATION PROCEDURE DIFFERENTIATES THE STIMULUS PROPERTIES OF MDMA AND d-AMPHETAMINE Behavioural Pharmacology. 10: S40. DOI: 10.1097/00008877-199908001-00098 |
0.501 |
|
| 1998 |
Baker LE, Svensson KA, Garner KJ, Goodwin AK. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. European Journal of Pharmacology. 358: 101-9. PMID 9808258 DOI: 10.1016/S0014-2999(98)00582-2 |
0.633 |
|
| Show low-probability matches. |